• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA? VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA? VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number H74939293086070
Medical Device Problem Codes Fracture (1260); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/19/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
G4 - premarket / 510(k) #: k133110, p090003.
 
Event or Problem Description
It was reported that stent damage occurred, requiring placement of another stent.The over 70% stenosed target lesion was located in the mildly tortuous and moderately calcified common iliac artery.An 8.0x30x75cm express ld stent was used for treatment.However, after deployment, an angiogram showed that the distal end of the stent was unraveled and appeared to fell apart.As a result, an express ld 8x20x135 was deployed to cover the portion of the previous stent.The catheter was removed with no issues, and the procedure was completed.The patient is expected to fully recover.
 
Additional Manufacturer Narrative
Additional information report is being filed to update d4 (lot number).
 
Event or Problem Description
It was reported that stent damage occurred, requiring placement of another stent.The over 70% stenosed target lesion was located in the mildly tortuous and moderately calcified common iliac artery.An 8.0x30x75cm express ld stent was used for treatment.However, after deployment, an angiogram showed that the distal end of the stent was unraveled and appeared to fell apart.As a result, an express ld 8x20x135 was deployed to cover the portion of the previous stent.The catheter was removed with no issues, and the procedure was completed.The patient is expected to fully recover.It was further reported that an innova self-expanding stent was used, and not an express ld stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA? VASCULAR
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key21632499
Report Number2124215-2025-16641
Device Sequence Number13072995
Product Code NIP
UDI-Device Identifier08714729873822
UDI-Public(01)08714729873822(17)291211(10)35476288
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P140028
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberH74939293086070
Device Catalogue NumberH74939293086070
Device Lot Number0035476288
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/20/2025
Supplement Date Received by Manufacturer03/31/2025
Initial Report FDA Received Date03/18/2025
Supplement Report FDA Received Date04/24/2025
Date Device Manufactured12/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-